Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Tranylcypromine tablets 10mg (Mercury Pharmaceuticals)
Section 19A approved medicine
(Approval lapsed) Tranylcypromine tablets 10mg (Mercury Pharmaceuticals)
Section 19A approval holder
Boucher and Muir Pty Ltd trading as BNM Group ABN 58 000 140 474
Phone
02 9431 6333
Approved until
Status
Expired
Medicines in short supply/unavailable
PARNATE tranylcypromine (as sulphate) 10mg film coated tablet blister pack - ARTG 174086
Indication(s)
Treatment of symptoms of depressive illness especially where treatment with other types of antidepressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.